Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KRTX Karuna Therapeutics > Detailed Quotes

KRTX Karuna Therapeutics

236.250
+6.650+2.90%
Close 10/04 16:00 ET
236.2500.0000.00%
Pre Mkt Price 10/05 04:04 ET
High
236.270
Open
232.810
Turnover
89.55M
Low
227.730
Pre Close
229.600
Volume
383.26K
Market Cap
7.90B
P/E(TTM)
Loss
52wk High
278.253
Shares
33.44M
P/E(Static)
Loss
52wk Low
92.260
Float Cap
6.30B
Bid/Ask %
0.00%
Historical High
278.253
Shs Float
26.68M
Volume Ratio
0.98
Historical Low
11.240
Dividend TTM
--
Div Yield TTM
--
P/B
19.49
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.44%
Amplitude
3.72%
Avg Price
233.650
Lot Size
1
Float Cap
6.30B
Bid/Ask %
0.00%
Historical High
278.253
Shs Float
26.68M
Volume Ratio
0.98
Historical Low
11.240
Dividend TTM
--
P/B
19.49
Dividend LFY
--
Turnover Ratio
1.44%
Amplitude
3.72%
Avg Price
233.650
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.
CEO: Dr. Steven M. Paul, M.D.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...